Characterization of noncompetitive regulators of proteasome activity

Methods in Enzymology

Volumn 398, Issue , 2005, Pages 425-438

  Gaczynska, Maria ^a   Osmulski, Pawel A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLIOTOXIN; PEPTIDE; PROLINE; PROTEASOME; PROTEASOME INHIBITOR; RITONAVIR;

ALLOSTERISM; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONFORMATIONAL TRANSITION; DRUG MECHANISM; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL;

EID: 27644500950     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)98035-X     Document Type: Review

References (22)

1. Adams J. The development of proteasome inhibitors as anticancer drugs Cancer Cell 5 2004 417 421
2. Bogyo M., McMaster J.S., Gaczynska M., Tortorella D., Goldberg A.L., and Ploegh H. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors Proc. Natl. Acad. Sci. USA 94 1997 6629 6634
3. Gaczynska M., and Osmulski P.A. Inhibitor at the gates, inhibitor in the chamber: Allosteric and competitive inhibitors of the proteasome as prospective drugs Curr. Med. Chem. Imunol. Endoc. Metab. Agents 2 2002 279 301
4. Gaczynska M., and Osmulski P.A. Small-molecule inhibitors of the proteasome activity C. Patterson D.M. Cyr "ubiquitin-proteasome protocols." Methods Mol. Biol. 2005 Humana Press 3 22
5. Gaczynska M., Osmulski P.A., Gao Y., Post M.J., and Simons M. Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity Biochemistry 42 2003 8663 8670
6. Gao Y.H., Lecker S., Post M.J., Hietaranta A.J., Li J., Volk R., Li M., Sato K., Saluja A.K., Steer M.L., Goldberg A.L., and Simons M. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide J. Clin. Invest. 106 2000 439 448
7. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., and Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution Nature 386 1997 463 471
8. Groll M., Bajorek M., Kohler A., Moroder L., Rubin D.M., Huber R., Glickman M.H., and Finley D. A gated channel into the proteasome core particle Nature Struct. Biol. 7 2000 1062 1067
9. Gunasekaran K., Ma B., and Nussinov R. Is allostery an intrinsic property of all dynamic proteins? Proteins Struct. Funct. Bioinform. 57 2004 433 443
10. Kisselev A.F., Akopian T.N., Castillo V., and Goldberg A.L. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown Mol. Cell 4 1999 395 402
11. Kisselev A.F., Garcia-Calvo M., Overkleeft H.S., Peterson E., Pennington M.W., Ploegh H.L., Thornberry N.A., and Goldberg A.L. The caspase-like sites of proteasomes, their substrate specificity, new inhibitors and substrates, and allosteric interactions with the trypsin-like sites J. Biol. Chem. 278 2003 35869 35877
12. Kisselev A.F., Kaganovich D., and Goldberg A.L. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes: Evidence for peptide-induced channel opening in the alpha-rings J. Biol. Chem. 277 2002 22260 22270
13. Kroll M., Arenzana-Seisdedos F., Bachelerie F., Thomas D., Friguet B., and Conconi M. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome Chem. Biol. 6 1999 689 698
14. Li J., and Rechsteiner M. Molecular dissection of the 11S REG (PA28) proteasome activators Biochimie 83 2001 373 383
15. Myung J., Kim K.B., Lindsten K., Dantuma N.P., and Crews C.M. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors Mol. Cell 7 2001 411 420
16. Osmulski P.A., and Gaczynska M. Nanoenzymology of the 20S proteasome: Proteasomal actions are controlled by the allosteric transition Biochemistry 41 2002 7047 7053
17. Osmulski P.A., and Gaczynska M. Atomic force microscopy of the proteasome Methods Enzymol. 398 34 2005 2005 (this volume).
18. Paugam A., Creuzet C., Dupouy-Camet J., and Roisin P. In vitro effects of gliotoxin, a natural proteasome inhibitor, on the infectivity and proteolytic activity of Toxoplasma gondii Parasitol. Res. 88 2002 785 787
19. Schmidtke G., Emch S., Groettrup M., and Holzhutter H.G. Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome J. Biol. Chem. 275 2000 22056 22063
20. Schmidtke G., Holzhutter H.G., Bogyo M., Kairies N., Groll M., de Giuli R., Emch S., and Groettrup M. How an inhibitor of the HIV-I protease modulates proteasome activity J. Biol. Chem. 274 1999 35734 35740
21. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity J. Leukocyte Biol. 75 2004 39 48
22. Zwickl P., Seemuller E., Kapelari B., and Baumeister W. The proteasome: A supramolecular assembly designed for controlled proteolysis Adv. Prot. Chem. 59 2001 187 222